Progressive Rapid Atherosclerotic Plaque Formation and Early Stent re-Stenosis in an Untreated CLL Patient; A Case

Mohammad Shojae1, Hosseinali Rostamipour2, Aref Ghanaatpisheh1,3

  • 1Cardiology Department Jahrom University of Medical Sciences Jahrom Iran.

Clinical Case Reports
|April 29, 2026
PubMed

Insights

This case study shows a rare link between chronic lymphocytic leukemia (CLL) and rapid coronary artery disease (CAD) progression. Patients with CLL may require closer cardiac monitoring due to accelerated atherosclerosis risks.

Area of Science:

  • Cardiology
  • Hematology
  • Oncology

Background:

  • Chronic lymphocytic leukemia (CLL) is a hematologic malignancy.
  • Coronary artery disease (CAD) is a leading cause of mortality.
  • The association between CLL and accelerated CAD is not well-established.

Purpose of the Study:

  • To report a case of a patient with CLL experiencing rapid CAD progression.
  • To explore potential mechanisms linking CLL and accelerated atherosclerosis.
  • To emphasize the importance of cardiac evaluation in CLL patients.

Main Methods:

  • Case report of a 66-year-old male with CLL and recurrent myocardial infarction.
  • Review of coronary angiography findings before and after percutaneous coronary intervention (PCI).
  • Analysis of laboratory results, including white blood cell (WBC) counts.

Main Results:

  • The patient experienced two non-ST elevation myocardial infarctions (NSTEMI) within six months.
  • Coronary angiography revealed progression from two-vessel to three-vessel disease, including in-stent restenosis.
  • White blood cell counts significantly increased, correlating with disease progression.

Conclusions:

  • CLL may be associated with accelerated CAD, potentially due to leukocyte aggregation, endothelial injury, or amyloid deposition.
  • Thorough cardiac evaluation is crucial for CLL patients.
  • Further research is needed to understand and manage this high-risk association.